ComboCap, Inc.

ComboCap, Inc.

The USA’s definitive “Combination Therapies Company” we’re bringing to market the new iconic ComboCap® Product Category

Founded 2012

United States 15 employees Private Equity Information Technology, Pharmaceutical

ComboCap, Inc., formerly known as Binutra USA, is a pioneering technology company that has created the groundbreaking ComboCap® Product Category. Founded in 2012, the company operates in the Pharmaceutical and Information Technology industries and is headquartered in the United States. The company's flagship product, the dual-chamber oral capsule with a movable membrane, has garnered substantial interest from investors. The patented technology developed by ComboCap, Inc. targets the rapidly expanding global market for combination therapy products, addressing the need for a universally appealing "wet & dry," split-dose solution. This innovative approach has attracted interest from private equity firm Athena Capital, which made a significant investment in the company on 01 January 2017. Recognizing the potential of ComboCap's specialized manufacturing equipment and services, investors have shown confidence in the company's ability to provide customized products and turn-key solutions to clients worldwide. As ComboCap, Inc. continues to make strides in the pharmaceutical and nutraceutical industries, its unique product offering and global potential position it as an intriguing investment opportunity for venture capitalists seeking innovation in the healthcare sector.

Funding Stage	Amount	Investors	Lead Investors	Date
Private Equity Round	Undisclosed	1	Athena Capital	01 Jan 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Private Equity Round

Undisclosed

Athena Capital

01 Jan 2017

FAQ About ComboCap, Inc.

The USA’s definitive “Combination Therapies Company” we’re bringing to market the new iconic ComboCap® Product Category

ComboCap, Inc. was founded in 2012.

ComboCap, Inc. is headquartered in United States.

ComboCap, Inc. operates in Information Technology and Pharmaceutical. Its work centres on Combination Therapies, Pharmaceutical Technology, Nutraceuticals and Dual-chamber Capsule.

ComboCap, Inc. has approximately 15 employees.

ComboCap, Inc. has completed 1 funding round. The latest funding stage is Private Equity.

Top alternatives and competitors to ComboCap, Inc. include Idesse. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

ComboCap, Inc. and Idesse are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About ComboCap, Inc.

Funding Rounds & Investors (1)

ComboCap, Inc. Alternatives & Competitors

FAQ About ComboCap, Inc.